Biologic treatment of psoriasis in oncologic patients (Unknown)
- New search for: Rusiñol, Lluís
- New search for: Camiña-Conforto, Gemma
- New search for: Puig, Luis
- New search for: Rusiñol, Lluís
- New search for: Camiña-Conforto, Gemma
- New search for: Puig, Luis
In:
Expert Opinion on Biological Therapy
;
22
, 12
;
1567-1578
;
2022
- Article (Journal) / Electronic Resource
-
Title:Biologic treatment of psoriasis in oncologic patients
-
Contributors:
-
Published in:Expert Opinion on Biological Therapy ; 22, 12 ; 1567-1578
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2022-12-02
-
Size:12 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 22, Issue 12
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1429
-
Biologics for psoriasis: is there any unmet need left?Feldman, Steven R / Menter, M Alan et al. | 2022
- 1431
-
New frontiers in personalized medicine in psoriasisCamela, Elisa / Potestio, Luca / Fabbrocini, Gabriella / Ruggiero, Angelo / Megna, Matteo et al. | 2022
- 1435
-
Paradoxical reactions to biologicals for psoriasisCamela, Elisa / Potestio, Luca / Fabbrocini, Gabriella / Megna, Matteo et al. | 2022
- 1439
-
Psoriatic arthritis improved on risankizumab: does the presence of psoriatic arthritis mean a drug approved for psoriatic arthritis has to be prescribed?Singh, Rohan / Brown, Alexandria M / Chan, Warren H / Farr, Morgan A / Venkataraman, Sid / Feldman, Steven R et al. | 2022
- 1443
-
Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndromeTrovato, Emanuele / Rubegni, Pietro / Prignano, Francesca et al. | 2022
- 1449
-
Biologic insights from single-cell studies of psoriasis and psoriatic arthritisJin, Joy Q / Wu, David / Spencer, Riley / Elhage, Kareem G / Liu, Jared / Davis, Mitchell / Hakimi, Marwa / Kumar, Sugandh / Huang, Zhi-Ming / Bhutani, Tina et al. | 2022
- 1463
-
Pathogenesis-oriented therapy of psoriasis using biologicsBoehncke, Wolf-Henning / Brembilla, Nicolò Costantino et al. | 2022
- 1475
-
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive reviewRosi, Elia / Fastame, Maria Thais / Di Cesare, Antonella / Prignano, Francesca et al. | 2022
- 1489
-
Anti-IL 23 biologics for the treatment of plaque psoriasisVu, Alan / Ulschmid, Caden / Gordon, Kenneth B. et al. | 2022
- 1503
-
Treating psoriasis in the elderly: biologics and small moleculesMegna, Matteo / Potestio, Luca / Fabbrocini, Gabriella / Camela, Elisa et al. | 2022
- 1521
-
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasisGisondi, Paolo / Geat, Davide / Bellinato, Francesco / Girolomoni, Giampiero et al. | 2022
- 1531
-
Biological treatment for erythrodermic psoriasisDogra, Sunil / Mehta, Hitaishi et al. | 2022
- 1545
-
What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis?Sunzini, Flavia / D’Antonio, Arianna / Fatica, Mauro / Triggianese, Paola / Conigliaro, Paola / Greco, Elisabetta / Bergamini, Alberto / Chimenti, Maria Sole et al. | 2022
- 1561
-
Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experienceBardazzi, Federico / Viviani, Filippo / Merli, Yuri / Di Lernia, Vito / Peccerillo, Francesca / Conti, Andrea / Lasagni, Claudia / Tabanelli, Michela / D’Adamio, Simone / Di Nuzzo, Sergio et al. | 2022
- 1567
-
Biologic treatment of psoriasis in oncologic patientsRusiñol, Lluís / Camiña-Conforto, Gemma / Puig, Luis et al. | 2022
- 1579
-
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasisGisondi, Paolo / Geat, Davide / Armeni, Patrizio / Bellinato, Francesco / Maurelli, Martina / Girolomoni, Giampiero et al. | 2022
- 1585
-
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 yearGalluzzo, Marco / Talamonti, Marina / Bernardini, Nicoletta / Chiricozzi, Andrea / De Simone, Clara / Bonifati, Claudio / Bruni, Pierluigi / Diotallevi, Federico / Esposito, Maria / Graceffa, Dario et al. | 2022
- i
-
Correction| 2022